相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabolic response evaluation for colorectal liver metastases and correlation to pathologic response and tumour markers
Lawrence F. Lau et al.
ANZ JOURNAL OF SURGERY (2018)
Loss of BMI-1 dampens migration and EMT of colorectal cancer in inflammatory microenvironment through TLR4/MD-2/MyD88-mediated NF-kappa B signaling
Kai Ye et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Activation of Vimentin Is Critical to Promote a Metastatic Potential of Cholangiocarcinoma Cells
Waraporn Saentaweesuk et al.
ONCOLOGY RESEARCH (2018)
The role of miRNA-21 and epithelial mesenchymal transition (EMT) process in colorectal cancer
Anelisa Jaca et al.
JOURNAL OF CLINICAL PATHOLOGY (2017)
Expression of epithelial-mesenchymal transition and cancer stem cell markers in colorectal adenocarcinoma: Clinicopathological significance
Ji Eun Choi et al.
ONCOLOGY REPORTS (2017)
Pleomorphic adenoma gene like-2 induces epithelial-mesenchymal transition via Wnt/β-catenin signaling pathway in human colorectal adenocarcinoma
Yong Peng Wang et al.
ONCOLOGY REPORTS (2017)
MicroRNA-194 modulates epithelial-mesenchymal transition in human colorectal cancer metastasis
Hong-Ke Cai et al.
ONCOTARGETS AND THERAPY (2017)
Epithelial-Mesenchymal Transition Phenotype, Metformin, and Survival for Colorectal Cancer Patients with Diabetes Mellitus II
Yaodu Wang et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2017)
Stromal Expression of Vimentin Predicts the Clinical Outcome of Stage II Colorectal Cancer for High-Risk Patients
Li-guo Liu et al.
MEDICAL SCIENCE MONITOR (2017)
The screening of the functional microRNA binding site SNPs in sporadic colorectal cancer genes
Hongjuan He et al.
CANCER BIOLOGY & THERAPY (2017)
Prognostic significance of the genetic and the immunohistochemical expression of epithelial-mesenchymal-related markers in colon cancer
Hayam E. Rashed et al.
CANCER BIOMARKERS (2017)
Elevated Preoperative Serum CEA Level Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma Through the Epithelial-Mesenchymal Transition
Masato Yoshikawa et al.
ANTICANCER RESEARCH (2017)
Cyclometalated Gold(III) Complexes Containing N-Heterocyclic Carbene Ligands Engage Multiple Anti-Cancer Molecular Targets
Sin Ki Fung et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Long non-coding RNA LINC01133 inhibits epithelial-mesenchymal transition and metastasis in colorectal cancer by interacting with SRSF6
Jianlu Kong et al.
CANCER LETTERS (2016)
Regulation of colorectal cancer cell epithelial to mesenchymal transition by the renin angiotensin system
Linh Nguyen et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications
Silvia Juliana Serrano-Gomez et al.
MOLECULAR CANCER (2016)
Anti-Cancer Activity of Solanum nigrum (AESN) through Suppression of Mitochondrial Function and Epithelial-Mesenchymal Transition (EMT) in Breast Cancer Cells
Ying-Jang Lai et al.
MOLECULES (2016)
miR-375 inhibits the invasion and metastasis of colorectal cancer via targeting SP1 and regulating EMT-associated genes
Fengyun Cui et al.
ONCOLOGY REPORTS (2016)
Prognostic Values of Vimentin Expression and Its Clinicopathological Significance in Non-Small Cell Lung Cancer: A Meta-Analysis of Observational Studies with 4118 Cases
Zhihua Ye et al.
PLOS ONE (2016)
Systematic review of the old and new concepts in the epithelial-mesenchymal transition of colorectal cancer
Simona Gurzu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Over expression of galectin-3 associates with short-term poor prognosis in stage II colon cancer
Zhiliang Huang et al.
CANCER BIOMARKERS (2016)
The Global Burden of Non-Hodgkin Lymphoma
Christina Fitzmaurice et al.
Clinical Lymphoma Myeloma & Leukemia (2015)
The prognostic significance of bromodomain PHD-finger transcription factor in colorectal carcinoma and association with vimentin and E-cadherin
Shuai Xiao et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2015)
Affinity proteomics led identification of vimentin as a potential biomarker in colon cancers: insights from serological screening and computational modelling
Shoiab Bukhari et al.
MOLECULAR BIOSYSTEMS (2015)
Bisdemethoxycurcumin suppresses migration and invasion of highly metastatic 95D lung cancer cells by regulating E-cadherin and vimentin expression, and inducing autophagy
Jinhong Xu et al.
MOLECULAR MEDICINE REPORTS (2015)
Prevalent and up-regulated vimentin expression in micropapillary components of lung adenocarcinomas and its adverse prognostic significance
Hiroyasu Nakashima et al.
PATHOLOGY INTERNATIONAL (2015)
EMT and tumor metastasis
Sarah Heerboth et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2015)
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
David Moher et al.
SYSTEMATIC REVIEWS (2015)
ILEI: a novel marker for epithelial-mesenchymal transition and poor prognosis in colorectal cancer
Zhao-Hua Gao et al.
HISTOPATHOLOGY (2014)
Loss of E-Cadherin Expression Is Associated with a Poor Prognosis in Stage III Colorectal Cancer
Jung-A Yun et al.
ONCOLOGY (2014)
Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer
Yuji Toiyama et al.
CARCINOGENESIS (2013)
A functional copy number variation in the WWOX gene is associated with lung cancer risk in Chinese
Lei Yang et al.
HUMAN MOLECULAR GENETICS (2013)
The meaning of the anti-cancer antibody CLN-IgG (Pritumumab) generated by human x human hybridoma technology against the cyto-skeletal protein, vimentin, in the course of the treatment of malignancy
Albert V. Hugwil
MEDICAL HYPOTHESES (2013)
Prognostic role of E-cadherin and Vimentin expression in various subtypes of soft tissue leiomyosarcomas
Wei Tian et al.
MEDICAL ONCOLOGY (2013)
Emerging evidence of epithelial-to-mesenchymal transition in lung carcinogenesis
Mitsuo Sato et al.
RESPIROLOGY (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Vimentin in cancer and its potential as a molecular target for cancer therapy
Arun Satelli et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
GRADE guidelines: 7. Rating the quality of evidence-inconsistency
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Vimentin expression of esophageal squamous cell carcinoma and its aggressive potential for lymph node metastasis
Hiroyuki Jin et al.
BIOMEDICAL RESEARCH-TOKYO (2010)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Vimentin Is a Novel Anti-Cancer Therapeutic Target; Insights from In Vitro and In Vivo Mice Xenograft Studies
Guy Lahat et al.
PLOS ONE (2010)
Biomarkers for epithelial-mesenchymal transitions
Michael Zeisberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion
Lorna McInroy et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer
C. Y. Ngan et al.
BRITISH JOURNAL OF CANCER (2007)
Complex networks orchestrate epithelial-mesenchymal transitions
JP Thiery et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Association of Vimentin overexpression and hepatocellular carcinoma metastasis
L Hu et al.
ONCOGENE (2004)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
Publication and related bias in meta-analysis: Power of statistical tests and prevalence in the literature
JAC Sterne et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2000)
分享论文
